Milton C. Ault III, Director at Alzamend Neuro, Inc. (ALZN), sold 2,000 shares at $1.56 ($3K) on 2026-08-26, disclosed to the SEC on 2026-08-31.
Open-market sale of $3k ALZN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UUU | BUY | 2026-09-24 | $79K | — | Filing → |
| GPUS | BUY | 2026-09-22 | $4K | — | Filing → |
| UUU | BUY | 2026-09-22 | $501 | — | Filing → |